Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elsamitrucin in Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00184080Phase 2Completed
- Sponsor
- University of Southern California
- Start
- May 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elsamitrucin in non-Hodgkin lymphoma (NHL), sponsored by University of Southern California. Started May 2004; status: completed.
02
Drugs
elsamitrucin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00184080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184080.